Abstract
Xonghong Xiao and colleagues analyze the challenge of antimicrobial resistance in China. A government strategy to promote rational use of antimicrobials in health care reduced antibiotic sales and percentage of prescriptions for antimicrobials for both hospitalized patients and outpatients, and offers insights to shape future initiatives. Please see later in the article for the Editors' Summary.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Bacterial Agents / therapeutic use*
-
China
-
Drug Prescriptions*
-
Drug Resistance*
-
Drug Utilization*
-
Health Policy*
-
Hospitalization
-
Humans
Grants and funding
YX is supported by the Research Special Fund for Public Welfare Industry of Health, Ministry of Health of China (201002021). The funders had no role in the analysis, decision to publish, or preparation of the manuscript.